The NDA for New Indication of Henlius Anti-PD-1 mAb Serplulimab in Combination with Chemotherapy for the First-line Treatment of non-squamous NSCLC Accepted by the NMPA
SHANGHAI, Dec. 12, 2023 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) announced that…
Chinese Reality Show "Divas Hit the Road" Invites Viewers to Experience the Charm of Silk Road, Serving as a Portal for International Cultural Exchanges
CHANGSHA, China, Dec. 12, 2023 /PRNewswire/ — Divas Hit the Road ("the…